Search Results - "MORITA, KAORU"
-
1
Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals
Published in Frontiers in immunology (14-06-2018)“…Inhibitory cytokines, such as transforming growth factor-β (TGF-β) and interleukin-10 (IL-10), are humoral factors involved in the suppressive function of…”
Get full text
Journal Article -
2
Relapsed and refractory multiple myeloma: A systematic review and network meta‐analysis of the efficacy of novel therapies
Published in British journal of haematology (01-03-2023)“…Summary The prognosis of multiple myeloma (MM) has dramatically improved with the development of new drugs, and it has become important to determine the…”
Get full text
Journal Article -
3
Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome
Published in Internal Medicine (01-11-2022)“…Tumor lysis syndrome (TLS) is a metabolic disorder caused by massive tumor lysis. Hypouricemic agents are administered to prevent TLS-related hyperuricemia and…”
Get full text
Journal Article -
4
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia
Published in Cancer science (01-04-2023)“…Nucleophosmin1 (NPM1) mutations are the most frequently detected gene mutations in acute myeloid leukemia (AML) and are considered a favorable prognostic…”
Get full text
Journal Article -
5
Risk Factors for Complications Associated with Peripherally Inserted Central Catheters During Induction Chemotherapy for Acute Myeloid Leukemia
Published in Internal Medicine (01-04-2022)“…Objective Peripherally inserted central catheters (PICCs) are widely used in patients with hematologic malignancies. However, the risks of PICC-related…”
Get full text
Journal Article -
6
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models
Published in PloS one (11-01-2021)“…Graft-versus-host disease is a major complication after allogeneic hematopoietic stem cell transplantation for hematological malignancies. Immunosuppressive…”
Get full text
Journal Article -
7
TGF-β3 Inhibits Antibody Production by Human B Cells
Published in PloS one (01-01-2017)“…TGF-β is a pleotropic cytokine involved in various biological processes. Of the three isoforms of TGF-β, TGF-β1 has long been recognized as an important…”
Get full text
Journal Article -
8
Factors Affecting Persistent Postoperative Pain in Patients with Hip Fractures
Published in Pain research & management (04-11-2020)“…Osteoporotic fractures are common among older people, and hip fractures (HF) can be devastating. Surgery is indicated for most cases of HF, and chronic…”
Get full text
Journal Article -
9
Effects of a Rehabilitation Program Combined with Pain Management That Targets Pain Perception and Activity Avoidance in Older Patients with Acute Vertebral Compression Fracture: a Randomised Controlled Trial
Published in Pain Research and Management (13-02-2023)“…This study aimed to investigate the effect of a rehabilitation program combined with pain management targeting pain perception and activity avoidance on…”
Get full text
Journal Article -
10
Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation
Published in Leukemia research (01-10-2022)“…Cardiotoxicity after allogeneic stem cell transplantation (SCT) is associated with a high rate of mortality and worsening quality of life. The relation between…”
Get full text
Journal Article -
11
Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies
Published in International journal of hematology (01-02-2019)“…We evaluated clinical outcomes of disseminated intravascular coagulation (DIC) in patients with hematological malignancies treated with synthetic protease…”
Get full text
Journal Article -
12
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study
Published in International journal of hematology (01-09-2020)“…Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) is one of the standard regimens for indolent B-cell non-Hodgkin’s lymphoma…”
Get full text
Journal Article -
13
Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma
Published in Annals of hematology (01-06-2022)“…Aprepitant (Apr) is an effective antiemetic agent for chemotherapy-induced nausea and vomiting (CINV). Current CINV guidelines recommend the antiemetic…”
Get full text
Journal Article -
14
Clinical association between thyroid disease and immune thrombocytopenia
Published in Annals of hematology (01-02-2021)“…Immune thrombocytopenia (ITP) can coexist with autoimmune thyroid disease. However, the detailed clinical features remain unknown. We retrospectively reviewed…”
Get full text
Journal Article -
15
Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index
Published in International journal of hematology (01-04-2019)“…Neutropenia is a major risk factor for opportunistic infections in patients with acute myeloid leukemia (AML) who undergo chemotherapy. In the present study,…”
Get full text
Journal Article -
16
Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis
Published in Modern rheumatology (01-05-2013)“…A 69-year-old man with sensorineural hearing loss and iritis was diagnosed with atypical Cogan’s syndrome. He had several systematic manifestations: aortitis,…”
Get full text
Journal Article -
17
The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin
Published in International journal of hematology (01-03-2020)“…The combination of dexamethasone, high-dose cytarabine, and cisplatin (DHAP) is used as salvage chemotherapy for relapsed or refractory lymphoma. It includes…”
Get full text
Journal Article -
18
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia
Published in International journal of hematology (01-08-2022)“…Recent studies have reported that measurable residual disease (MRD) analysis using NPM1 mutations helps determine whether allogeneic hematopoietic stem cell…”
Get full text
Journal Article -
19
Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors
Published in Bone marrow transplantation (Basingstoke) (01-03-2021)“…In allogeneic hematopoietic stem cell transplantation (allo-HSCT), the effects of patient and donor human leukocyte antigen (HLA) matching status on…”
Get full text
Journal Article -
20
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma
Published in Annals of hematology (01-12-2020)“…The amount of infused CD34 + cells has been reported to be the strongest predictor of platelet recovery after autologous stem cell transplantation (ASCT)…”
Get full text
Journal Article